Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Mol Psychiatry

Retrieve available abstracts of 204 articles:
HTML format



Single Articles


    July 2021
  1. MURPHY CE, Weickert CS
    A new suspect in the unsolved case of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2021 Jul 20. pii: 10.1038/s41380-021-01225.
    PubMed    


  2. WU X, Shukla R, Alganem K, Zhang X, et al
    Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity.
    Mol Psychiatry. 2021 Jul 16. pii: 10.1038/s41380-021-01205.
    PubMed     Abstract available


  3. HEURICH M, Focking M, Mongan D, Cagney G, et al
    Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis.
    Mol Psychiatry. 2021 Jul 5. pii: 10.1038/s41380-021-01197.
    PubMed     Abstract available


  4. SHA Z, Schijven D, Francks C
    Patterns of brain asymmetry associated with polygenic risks for autism and schizophrenia implicate language and executive functions but not brain masculinization.
    Mol Psychiatry. 2021 Jul 1. pii: 10.1038/s41380-021-01204.
    PubMed     Abstract available


    June 2021
  5. ZHU X, Cabungcal JH, Cuenod M, Uliana DL, et al
    Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine.
    Mol Psychiatry. 2021 Jun 30. pii: 10.1038/s41380-021-01198.
    PubMed     Abstract available


  6. GUAN F, Ni T, Zhu W, Williams LK, et al
    Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.
    Mol Psychiatry. 2021 Jun 30. pii: 10.1038/s41380-021-01201.
    PubMed     Abstract available


  7. GAO WJ, Yang SS, Mack NR, Chamberlin LA, et al
    Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction.
    Mol Psychiatry. 2021 Jun 23. pii: 10.1038/s41380-021-01196.
    PubMed     Abstract available


  8. ROGDAKI M, Devroye C, Ciampoli M, Veronese M, et al
    Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Mol Psychiatry. 2021 Jun 22. pii: 10.1038/s41380-021-01192.
    PubMed    


  9. RADHAKRISHNAN R, Skosnik PD, Ranganathan M, Naganawa M, et al
    In vivo evidence of lower synaptic vesicle density in schizophrenia.
    Mol Psychiatry. 2021 Jun 16. pii: 10.1038/s41380-021-01184.
    PubMed     Abstract available


  10. DEMICHELE-SWEET MAA, Klei L, Creese B, Harwood JC, et al
    Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
    Mol Psychiatry. 2021 Jun 10. pii: 10.1038/s41380-021-01152.
    PubMed     Abstract available


    May 2021
  11. WEISSLEDER C, North HF, Bitar M, Fullerton JM, et al
    Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia.
    Mol Psychiatry. 2021 May 31. pii: 10.1038/s41380-021-01149.
    PubMed     Abstract available


  12. DI BIASE MA, Cetin-Karayumak S, Lyall AE, Zalesky A, et al
    White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.
    Mol Psychiatry. 2021 May 24. pii: 10.1038/s41380-021-01128.
    PubMed     Abstract available


  13. CHADHA R, Alganem K, Mccullumsmith RE, Meador-Woodruff JH, et al
    mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
    Mol Psychiatry. 2021 May 14. pii: 10.1038/s41380-021-01135.
    PubMed     Abstract available


  14. KARIMI B, Silwal P, Booth S, Padmanabhan N, et al
    Schizophrenia-associated LRRTM1 regulates cognitive behavior through controlling synaptic function in the mediodorsal thalamus.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01146.
    PubMed     Abstract available


  15. ROGDAKI M, Devroye C, Ciampoli M, Veronese M, et al
    Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01108.
    PubMed     Abstract available


  16. SELLGREN CM, Imbeault S, Larsson MK, Oliveros A, et al
    GRK3 deficiency elicits brain immune activation and psychosis.
    Mol Psychiatry. 2021 May 12. pii: 10.1038/s41380-021-01106.
    PubMed     Abstract available


    April 2021
  17. LI Y, Ma C, Li W, Yang Y, et al
    A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.
    Mol Psychiatry. 2021 Apr 30. pii: 10.1038/s41380-021-01125.
    PubMed     Abstract available


  18. SHEN M, Guo Y, Dong Q, Gao Y, et al
    FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors.
    Mol Psychiatry. 2021 Apr 16. pii: 10.1038/s41380-021-01096.
    PubMed     Abstract available


  19. DRUART M, Nosten-Bertrand M, Poll S, Crux S, et al
    Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes.
    Mol Psychiatry. 2021 Apr 9. pii: 10.1038/s41380-021-01081.
    PubMed     Abstract available


  20. ANDLAUER TFM, Guzman-Parra J, Streit F, Strohmaier J, et al
    Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders.
    Mol Psychiatry. 2021;26:1286-1298.
    PubMed     Abstract available


  21. LEGGIO GM, Torrisi SA, Mastrogiacomo R, Mauro D, et al
    The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.
    Mol Psychiatry. 2021;26:1272-1285.
    PubMed     Abstract available


    March 2021
  22. ZHANG CY, Xiao X, Zhang Z, Hu Z, et al
    An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data.
    Mol Psychiatry. 2021 Mar 8. pii: 10.1038/s41380-021-01037.
    PubMed     Abstract available


  23. TAKAHASHI Y, Maynard KR, Tippani M, Jaffe AE, et al
    Single molecule in situ hybridization reveals distinct localizations of schizophrenia risk-related transcripts SNX19 and AS3MT in human brain.
    Mol Psychiatry. 2021 Mar 1. pii: 10.1038/s41380-021-01046.
    PubMed     Abstract available


  24. SINHA V, Ukkola-Vuoti L, Ortega-Alonso A, Torniainen-Holm M, et al
    Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population.
    Mol Psychiatry. 2021;26:816-824.
    PubMed     Abstract available


    February 2021
  25. GRUBISHA MJ, Sun X, MacDonald ML, Garver M, et al
    MAP2 is differentially phosphorylated in schizophrenia, altering its function.
    Mol Psychiatry. 2021 Feb 1. pii: 10.1038/s41380-021-01034.
    PubMed     Abstract available


  26. RATHJE M, Waxman H, Benoit M, Tammineni P, et al
    Genetic variants in the bipolar disorder risk locus SYNE1 that affect CPG2 expression and protein function.
    Mol Psychiatry. 2021;26:508-523.
    PubMed     Abstract available


    January 2021
  27. CUI X, McGrath JJ, Burne THJ, Eyles DW, et al
    Vitamin D and schizophrenia: 20 years on.
    Mol Psychiatry. 2021 Jan 26. pii: 10.1038/s41380-021-01025.
    PubMed     Abstract available


  28. RATANATHARATHORN A, Koenen KC, Chibnik LB, Weisskopf MG, et al
    Polygenic risk for autism, attention-deficit hyperactivity disorder, schizophrenia, major depressive disorder, and neuroticism is associated with the experience of childhood abuse.
    Mol Psychiatry. 2021 Jan 22. pii: 10.1038/s41380-020-00996.
    PubMed     Abstract available


  29. SEITZ-HOLLAND J, Cetin-Karayumak S, Wojcik JD, Lyall A, et al
    Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.
    Mol Psychiatry. 2021 Jan 22. pii: 10.1038/s41380-021-01018.
    PubMed     Abstract available


  30. HUANG Y, Jiang H, Zheng Q, Fok AHK, et al
    Environmental enrichment or selective activation of parvalbumin-expressing interneurons ameliorates synaptic and behavioral deficits in animal models with schizophrenia-like behaviors during adolescence.
    Mol Psychiatry. 2021 Jan 20. pii: 10.1038/s41380-020-01005.
    PubMed     Abstract available


  31. WANG D, Peng X, Pelletier-Baldelli A, Orlov N, et al
    Altered temporal, but intact spatial, features of transient network dynamics in psychosis.
    Mol Psychiatry. 2021 Jan 18. pii: 10.1038/s41380-020-00983.
    PubMed     Abstract available


  32. TARANTINO N, Leboyer M, Bouleau A, Hamdani N, et al
    Natural killer cells in first-episode psychosis: an innate immune signature?
    Mol Psychiatry. 2021 Jan 17. pii: 10.1038/s41380-020-01008.
    PubMed     Abstract available


  33. ROESKE MJ, McHugo M, Vandekar S, Blackford JU, et al
    Incomplete hippocampal inversion in schizophrenia: prevalence, severity, and impact on hippocampal structure.
    Mol Psychiatry. 2021 Jan 12. pii: 10.1038/s41380-020-01010.
    PubMed     Abstract available


  34. ROOSTERMAN D, Cottrell GS
    The two-cell model of glucose metabolism: a hypothesis of schizophrenia.
    Mol Psychiatry. 2021 Jan 5. pii: 10.1038/s41380-020-00980.
    PubMed     Abstract available


  35. LI M, Li Y, Qin H, Tubbs JD, et al
    Correction: Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population.
    Mol Psychiatry. 2021 Jan 4. pii: 10.1038/s41380-020-01013.
    PubMed    


  36. NORTHOFF G, Hirjak D, Wolf RC, Magioncalda P, et al
    All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders.
    Mol Psychiatry. 2021;26:92-102.
    PubMed     Abstract available


    December 2020
  37. HUANG Y, Huang J, Zhou QX, Yang CX, et al
    ZFP804A mutant mice display sex-dependent schizophrenia-like behaviors.
    Mol Psychiatry. 2020 Dec 10. pii: 10.1038/s41380-020-00972.
    PubMed     Abstract available


  38. LI M, Li Y, Qin H, Tubbs JD, et al
    Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population.
    Mol Psychiatry. 2020 Dec 5. pii: 10.1038/s41380-020-00968.
    PubMed     Abstract available


  39. LICINIO J, Wong ML
    Advances in schizophrenia research: glycobiology, white matter abnormalities, and their interactions.
    Mol Psychiatry. 2020;25:3116-3118.
    PubMed    


    November 2020
  40. MARX W, McGuinness AJ, Rocks T, Ruusunen A, et al
    The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
    Mol Psychiatry. 2020 Nov 23. pii: 10.1038/s41380-020-00951.
    PubMed     Abstract available


  41. TROMP A, Mowry B, Giacomotto J
    Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.
    Mol Psychiatry. 2020 Nov 15. pii: 10.1038/s41380-020-00944.
    PubMed     Abstract available


  42. GIRGIS RR, Slifstein M, Brucato G, Kegeles LS, et al
    Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [(11)C]-(+)-PHNO PET with methylphenidate challenge study.
    Mol Psychiatry. 2020 Nov 5. pii: 10.1038/s41380-020-00934.
    PubMed     Abstract available


  43. ZIMMERMAN AJ, Hafez AK, Amoah SK, Rodriguez BA, et al
    A psychiatric disease-related circular RNA controls synaptic gene expression and cognition.
    Mol Psychiatry. 2020;25:2712-2727.
    PubMed     Abstract available


  44. MANCINI V, Sandini C, Padula MC, Zoller D, et al
    Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
    Mol Psychiatry. 2020;25:2844-2859.
    PubMed     Abstract available


  45. VAN DER MEER D, Rokicki J, Kaufmann T, Cordova-Palomera A, et al
    Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes.
    Mol Psychiatry. 2020;25:3053-3065.
    PubMed     Abstract available


    October 2020
  46. COUGHLIN JM, Yang K, Marsman A, Pradhan S, et al
    A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia.
    Mol Psychiatry. 2020 Oct 19. pii: 10.1038/s41380-020-00901.
    PubMed     Abstract available


  47. POLLAK TA, Kempton MJ, Iyegbe C, Vincent A, et al
    Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
    Mol Psychiatry. 2020 Oct 19. pii: 10.1038/s41380-020-00899.
    PubMed     Abstract available


  48. LIZANO P, Lutz O, Xu Y, Rubin LH, et al
    Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis.
    Mol Psychiatry. 2020 Oct 15. pii: 10.1038/s41380-020-00914.
    PubMed     Abstract available


  49. SCHWARZ E, Alnaes D, Andreassen OA, Cao H, et al
    Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap.
    Mol Psychiatry. 2020 Oct 15. pii: 10.1038/s41380-020-00915.
    PubMed    


  50. HAARSMA J, Fletcher PC, Griffin JD, Taverne HJ, et al
    Correction: Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.
    Mol Psychiatry. 2020 Oct 14. pii: 10.1038/s41380-020-00919.
    PubMed     Abstract available


  51. LAGO SG, Tomasik J, van Rees GF, Ramsey JM, et al
    Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.
    Mol Psychiatry. 2020;25:2355-2372.
    PubMed     Abstract available


    September 2020
  52. LV J, Di Biase M, Cash RFH, Cocchi L, et al
    Individual deviations from normative models of brain structure in a large cross-sectional schizophrenia cohort.
    Mol Psychiatry. 2020 Sep 22. pii: 10.1038/s41380-020-00882.
    PubMed     Abstract available


  53. KIM S, Shin SH, Santangelo B, Veronese M, et al
    Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [(18)F]DOPA and [(11)C]raclopride PET study in first-episode psychosis.
    Mol Psychiatry. 2020 Sep 14. pii: 10.1038/s41380-020-00879.
    PubMed     Abstract available


  54. DING C, Zhang C, Kopp R, Kuney L, et al
    Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia.
    Mol Psychiatry. 2020 Sep 14. pii: 10.1038/s41380-020-00877.
    PubMed     Abstract available


    August 2020
  55. SAWADA T, Chater TE, Sasagawa Y, Yoshimura M, et al
    Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids.
    Mol Psychiatry. 2020 Aug 7. pii: 10.1038/s41380-020-0844.
    PubMed     Abstract available


  56. THAPAR A, Riglin L
    The importance of a developmental perspective in Psychiatry: what do recent genetic-epidemiological findings show?
    Mol Psychiatry. 2020;25:1631-1639.
    PubMed     Abstract available


  57. ROGDAKI M, Gudbrandsen M, McCutcheon RA, Blackmore CE, et al
    Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.
    Mol Psychiatry. 2020;25:1704-1717.
    PubMed     Abstract available


    July 2020
  58. ROESKE MJ, Konradi C, Heckers S, Lewis AS, et al
    Hippocampal volume and hippocampal neuron density, number and size in schizophrenia: a systematic review and meta-analysis of postmortem studies.
    Mol Psychiatry. 2020 Jul 28. pii: 10.1038/s41380-020-0853.
    PubMed     Abstract available


  59. THYGESEN JH, Presman A, Harju-Seppanen J, Irizar H, et al
    Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study.
    Mol Psychiatry. 2020 Jul 27. pii: 10.1038/s41380-020-0820.
    PubMed     Abstract available


  60. MCNALLY JM, Aguilar DD, Katsuki F, Radzik LK, et al
    Optogenetic manipulation of an ascending arousal system tunes cortical broadband gamma power and reveals functional deficits relevant to schizophrenia.
    Mol Psychiatry. 2020 Jul 20. pii: 10.1038/s41380-020-0840.
    PubMed     Abstract available


  61. FOURNIER M, Scolamiero M, Gholam-Rezaee MM, Cleusix M, et al
    Topology predicts long-term functional outcome in early psychosis.
    Mol Psychiatry. 2020 Jul 6. pii: 10.1038/s41380-020-0826.
    PubMed     Abstract available


    June 2020
  62. CONEN S, Gregory CJ, Hinz R, Smallman R, et al
    Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis.
    Mol Psychiatry. 2020 Jun 30. pii: 10.1038/s41380-020-0829.
    PubMed     Abstract available


  63. HAARSMA J, Fletcher PC, Griffin JD, Taverne HJ, et al
    Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.
    Mol Psychiatry. 2020 Jun 24. pii: 10.1038/s41380-020-0803.
    PubMed     Abstract available


  64. REGEN F, Cosma NC, Otto LR, Clemens V, et al
    Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophrenia.
    Mol Psychiatry. 2020 Jun 2. pii: 10.1038/s41380-020-0791.
    PubMed     Abstract available


    May 2020
  65. PRICE AJ, Jaffe AE, Weinberger DR
    Cortical cellular diversity and development in schizophrenia.
    Mol Psychiatry. 2020 May 13. pii: 10.1038/s41380-020-0775.
    PubMed     Abstract available


  66. WILLIAMS SE, Mealer RG, Scolnick EM, Smoller JW, et al
    Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies.
    Mol Psychiatry. 2020 May 13. pii: 10.1038/s41380-020-0761.
    PubMed     Abstract available


  67. KRAGULJAC NV, Anthony T, Morgan CJ, Jindal RD, et al
    White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naive first-episode psychosis patients.
    Mol Psychiatry. 2020 May 12. pii: 10.1038/s41380-020-0765.
    PubMed     Abstract available


  68. KOKKINOU M, Irvine EE, Bonsall DR, Natesan S, et al
    Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
    Mol Psychiatry. 2020 May 7. pii: 10.1038/s41380-020-0740.
    PubMed     Abstract available


  69. ZHANG R, Larsen JT, Kuja-Halkola R, Thornton L, et al
    Familial co-aggregation of schizophrenia and eating disorders in Sweden and Denmark.
    Mol Psychiatry. 2020 May 7. pii: 10.1038/s41380-020-0749.
    PubMed     Abstract available


  70. MEALER RG, Williams SE, Daly MJ, Scolnick EM, et al
    Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research.
    Mol Psychiatry. 2020 May 6. pii: 10.1038/s41380-020-0753.
    PubMed     Abstract available


    April 2020
  71. MARQUES TR, Ashok AH, Angelescu I, Borgan F, et al
    GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513.
    Mol Psychiatry. 2020 Apr 15. pii: 10.1038/s41380-020-0711.
    PubMed     Abstract available


  72. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    Differences in fractional anisotropy between the patients with schizophrenia and healthy comparison subjects.
    Mol Psychiatry. 2020;25:697-698.
    PubMed    


  73. LICINIO J
    Advances in schizophrenia research: first special issue, 2020.
    Mol Psychiatry. 2020;25:699-700.
    PubMed    


  74. PASSOS IC, Mwangi B
    Machine learning-guided intervention trials to predict treatment response at an individual patient level: an important second step following randomized clinical trials.
    Mol Psychiatry. 2020;25:701-702.
    PubMed    


  75. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals.
    Mol Psychiatry. 2020;25:883-895.
    PubMed     Abstract available


    March 2020
  76. DWIR D, Giangreco B, Xin L, Tenenbaum L, et al
    Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
    Mol Psychiatry. 2020 Mar 26. pii: 10.1038/s41380-020-0716.
    PubMed     Abstract available


  77. DEMPSTER K, Jeon P, MacKinley M, Williamson P, et al
    Early treatment response in first episode psychosis: a 7-T magnetic resonance spectroscopic study of glutathione and glutamate.
    Mol Psychiatry. 2020 Mar 24. pii: 10.1038/s41380-020-0704.
    PubMed     Abstract available


  78. PEREZ JM, Berto S, Gleason K, Ghose S, et al
    Hippocampal subfield transcriptome analysis in schizophrenia psychosis.
    Mol Psychiatry. 2020 Mar 9. pii: 10.1038/s41380-020-0696.
    PubMed     Abstract available


  79. CAO H, Zhou H, Cannon TD
    Functional connectome-wide associations of schizophrenia polygenic risk.
    Mol Psychiatry. 2020 Mar 3. pii: 10.1038/s41380-020-0699.
    PubMed     Abstract available


  80. GORDOVEZ FJA, McMahon FJ
    The genetics of bipolar disorder.
    Mol Psychiatry. 2020;25:544-559.
    PubMed     Abstract available


  81. SONDERBY IE, Gustafsson O, Doan NT, Hibar DP, et al
    Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.
    Mol Psychiatry. 2020;25:584-602.
    PubMed     Abstract available


    February 2020
  82. ANDREOU C, Borgwardt S
    Structural and functional imaging markers for susceptibility to psychosis.
    Mol Psychiatry. 2020 Feb 17. pii: 10.1038/s41380-020-0679.
    PubMed     Abstract available


  83. MA L, Shcherbina A, Chetty S
    Variations and expression features of CYP2D6 contribute to schizophrenia risk.
    Mol Psychiatry. 2020 Feb 11. pii: 10.1038/s41380-020-0675.
    PubMed     Abstract available


  84. NI C, Jiang W, Wang Z, Wang Z, et al
    LncRNA-AC006129.1 reactivates a SOCS3-mediated anti-inflammatory response through DNA methylation-mediated CIC downregulation in schizophrenia.
    Mol Psychiatry. 2020 Feb 3. pii: 10.1038/s41380-020-0662.
    PubMed     Abstract available


  85. CLEYNEN I, Engchuan W, Hestand MS, Heung T, et al
    Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.
    Mol Psychiatry. 2020 Feb 3. pii: 10.1038/s41380-020-0654.
    PubMed     Abstract available


  86. CHASE HW, Boudewyn MA, Carter CS, Phillips ML, et al
    Transcranial direct current stimulation: a roadmap for research, from mechanism of action to clinical implementation.
    Mol Psychiatry. 2020;25:397-407.
    PubMed     Abstract available


    January 2020
  87. SMIGIELSKI L, Jagannath V, Rossler W, Walitza S, et al
    Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings.
    Mol Psychiatry. 2020 Jan 6. pii: 10.1038/s41380-019-0601.
    PubMed     Abstract available


  88. YANG Z, Zhou D, Li H, Cai X, et al
    The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.
    Mol Psychiatry. 2020;25:48-66.
    PubMed     Abstract available


  89. BARESIC A, Nash AJ, Dahoun T, Howes O, et al
    Understanding the genetics of neuropsychiatric disorders: the potential role of genomic regulatory blocks.
    Mol Psychiatry. 2020;25:6-18.
    PubMed     Abstract available


  90. REN M, Hu Z, Chen Q, Jaffe A, et al
    KCNH2-3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits.
    Mol Psychiatry. 2020;25:206-229.
    PubMed     Abstract available


  91. KENDLER KS
    The development of Kraepelin's mature diagnostic concept of hebephrenia: a close reading of relevant texts of Hecker, Daraszkiewicz, and Kraepelin.
    Mol Psychiatry. 2020;25:180-193.
    PubMed     Abstract available


  92. KANO SI, Hodgkinson CA, Jones-Brando L, Eastwood S, et al
    Host-parasite interaction associated with major mental illness.
    Mol Psychiatry. 2020;25:194-205.
    PubMed     Abstract available


    December 2019
  93. GOBSHTIS N, Tfilin M, Fraifeld VE, Turgeman G, et al
    Transplantation of mesenchymal stem cells causes long-term alleviation of schizophrenia-like behaviour coupled with increased neurogenesis.
    Mol Psychiatry. 2019 Dec 11. pii: 10.1038/s41380-019-0623.
    PubMed     Abstract available


  94. GREENING DW, Notaras M, Chen M, Xu R, et al
    Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome.
    Mol Psychiatry. 2019 Dec 10. pii: 10.1038/s41380-019-0617.
    PubMed     Abstract available


  95. BORGAN F, O'Daly O, Veronese M, Reis Marques T, et al
    The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study.
    Mol Psychiatry. 2019 Dec 4. pii: 10.1038/s41380-019-0619.
    PubMed     Abstract available


    November 2019
  96. KOWALEC K, Lu Y, Sariaslan A, Song J, et al
    Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.
    Mol Psychiatry. 2019 Nov 12. pii: 10.1038/s41380-019-0575.
    PubMed     Abstract available


  97. GORDON A, Forsingdal A, Klewe IV, Nielsen J, et al
    Transcriptomic networks implicate neuronal energetic abnormalities in three mouse models harboring autism and schizophrenia-associated mutations.
    Mol Psychiatry. 2019 Nov 8. pii: 10.1038/s41380-019-0576.
    PubMed     Abstract available


  98. D'AMBROSIO E, Jauhar S, Kim S, Veronese M, et al
    The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal (18)F-DOPA PET and voxel-based morphometry study.
    Mol Psychiatry. 2019 Nov 5. pii: 10.1038/s41380-019-0570.
    PubMed     Abstract available


    October 2019
  99. REAY WR, Cairns MJ
    The role of the retinoids in schizophrenia: genomic and clinical perspectives.
    Mol Psychiatry. 2019 Oct 30. pii: 10.1038/s41380-019-0566.
    PubMed     Abstract available


  100. ZHANG X, Yang M, Du X, Liao W, et al
    Correction: Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Mol Psychiatry. 2019 Oct 22. pii: 10.1038/s41380-019-0552.
    PubMed     Abstract available


  101. BIGDELI TB, Genovese G, Georgakopoulos P, Meyers JL, et al
    Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry.
    Mol Psychiatry. 2019 Oct 7. pii: 10.1038/s41380-019-0517.
    PubMed     Abstract available


  102. KIM P, Scott MR, Meador-Woodruff JH
    Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia.
    Mol Psychiatry. 2019 Oct 2. pii: 10.1038/s41380-019-0537.
    PubMed     Abstract available


    September 2019
  103. CETIN-KARAYUMAK S, Di Biase MA, Chunga N, Reid B, et al
    White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.
    Mol Psychiatry. 2019 Sep 11. pii: 10.1038/s41380-019-0509.
    PubMed     Abstract available


  104. HESS JL, Tylee DS, Mattheisen M, Borglum AD, et al
    A polygenic resilience score moderates the genetic risk for schizophrenia.
    Mol Psychiatry. 2019 Sep 6. pii: 10.1038/s41380-019-0463.
    PubMed     Abstract available


    August 2019
  105. MCCUTCHEON RA, Pillinger T, Mizuno Y, Montgomery A, et al
    The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.
    Mol Psychiatry. 2019 Aug 30. pii: 10.1038/s41380-019-0502.
    PubMed     Abstract available


  106. TIAN X, Richard A, El-Saadi MW, Bhandari A, et al
    Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model.
    Mol Psychiatry. 2019 Aug 23. pii: 10.1038/s41380-019-0492.
    PubMed     Abstract available


  107. WOO JJ, Pouget JG, Zai CC, Kennedy JL, et al
    The complement system in schizophrenia: where are we now and what's next?
    Mol Psychiatry. 2019 Aug 22. pii: 10.1038/s41380-019-0479.
    PubMed     Abstract available


  108. ZHANG X, Yang M, Du X, Liao W, et al
    Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Mol Psychiatry. 2019 Aug 13. pii: 10.1038/s41380-019-0478.
    PubMed     Abstract available


  109. ZHU F, Guo R, Wang W, Ju Y, et al
    Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.
    Mol Psychiatry. 2019 Aug 7. pii: 10.1038/s41380-019-0475.
    PubMed     Abstract available


  110. LI H, Zhu Y, Morozov YM, Chen X, et al
    Disruption of TCF4 regulatory networks leads to abnormal cortical development and mental disabilities.
    Mol Psychiatry. 2019;24:1235-1246.
    PubMed     Abstract available


    July 2019
  111. NI P, Noh H, Park GH, Shao Z, et al
    Correction: iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.
    Mol Psychiatry. 2019 Jul 31. pii: 10.1038/s41380-019-0467.
    PubMed     Abstract available


  112. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Correction: Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jul 15. pii: 10.1038/s41380-019-0456.
    PubMed     Abstract available


    June 2019
  113. PURVES-TYSON TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, et al
    Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation.
    Mol Psychiatry. 2019 Jun 5. pii: 10.1038/s41380-019-0434.
    PubMed     Abstract available


  114. SONE D, Beheshti I, Maikusa N, Ota M, et al
    Neuroimaging-based brain-age prediction in diverse forms of epilepsy: a signature of psychosis and beyond.
    Mol Psychiatry. 2019 Jun 3. pii: 10.1038/s41380-019-0446.
    PubMed     Abstract available


    May 2019
  115. ROSATO M, Stringer S, Gebuis T, Paliukhovich I, et al
    Combined cellomics and proteomics analysis reveals shared neuronal morphology and molecular pathway phenotypes for multiple schizophrenia risk genes.
    Mol Psychiatry. 2019 May 29. pii: 10.1038/s41380-019-0436.
    PubMed     Abstract available


  116. LESH TA, Maddock RJ, Howell A, Wang H, et al
    Extracellular free water and glutathione in first-episode psychosis-a multimodal investigation of an inflammatory model for psychosis.
    Mol Psychiatry. 2019 May 28. pii: 10.1038/s41380-019-0428.
    PubMed     Abstract available


  117. DIACONESCU AO, Hauke DJ, Borgwardt S
    Models of persecutory delusions: a mechanistic insight into the early stages of psychosis.
    Mol Psychiatry. 2019 May 10. pii: 10.1038/s41380-019-0427.
    PubMed     Abstract available


    April 2019
  118. NI P, Noh H, Park GH, Shao Z, et al
    iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.
    Mol Psychiatry. 2019 Apr 24. pii: 10.1038/s41380-019-0423.
    PubMed     Abstract available


  119. RUTKOWSKI TP, Purcell RH, Pollak RM, Grewenow SM, et al
    Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
    Mol Psychiatry. 2019 Apr 11. pii: 10.1038/s41380-019-0413.
    PubMed     Abstract available


  120. KINDLER J, Lim CK, Weickert CS, Boerrigter D, et al
    Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.
    Mol Psychiatry. 2019 Apr 3. pii: 10.1038/s41380-019-0401.
    PubMed     Abstract available


    March 2019
  121. DWIR D, Giangreco B, Xin L, Tenenbaum L, et al
    MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
    Mol Psychiatry. 2019 Mar 25. pii: 10.1038/s41380-019-0393.
    PubMed     Abstract available


  122. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0373.
    PubMed     Abstract available


  123. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0381.
    PubMed     Abstract available


  124. LEGGE SE, Pardinas AF, Helthuis M, Jansen JA, et al
    A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia.
    Mol Psychiatry. 2019;24:328-337.
    PubMed     Abstract available


  125. HORWITZ T, Lam K, Chen Y, Xia Y, et al
    A decade in psychiatric GWAS research.
    Mol Psychiatry. 2019;24:378-389.
    PubMed     Abstract available


    February 2019
  126. COLIZZI M, Weltens N, McGuire P, Lythgoe D, et al
    Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
    Mol Psychiatry. 2019 Feb 15. pii: 10.1038/s41380-019-0374.
    PubMed     Abstract available


  127. ROALF DR, de la Garza AG, Rosen A, Calkins ME, et al
    Alterations in white matter microstructure in individuals at persistent risk for psychosis.
    Mol Psychiatry. 2019 Feb 5. pii: 10.1038/s41380-019-0360.
    PubMed     Abstract available


    January 2019
  128. HADAR R, Winter R, Edemann-Callesen H, Wieske F, et al
    Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats.
    Mol Psychiatry. 2019 Jan 28. pii: 10.1038/s41380-019-0356.
    PubMed     Abstract available


  129. SCOTT MR, Meador-Woodruff JH
    Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects.
    Mol Psychiatry. 2019 Jan 25. pii: 10.1038/s41380-019-0359.
    PubMed     Abstract available


  130. WARLAND A, Kendall KM, Rees E, Kirov G, et al
    Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank.
    Mol Psychiatry. 2019 Jan 24. pii: 10.1038/s41380-019-0355.
    PubMed     Abstract available


  131. MA L, Semick SA, Chen Q, Li C, et al
    Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19).
    Mol Psychiatry. 2019 Jan 11. pii: 10.1038/s41380-018-0293.
    PubMed     Abstract available


  132. AMARE AT, Vaez A, Hsu YH, Direk N, et al
    Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
    Mol Psychiatry. 2019 Jan 9. pii: 10.1038/s41380-018-0336.
    PubMed     Abstract available


  133. ESCOTT-PRICE V, Bracher-Smith M, Menzies G, Walters J, et al
    Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank.
    Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0328.
    PubMed    


  134. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0332.
    PubMed     Abstract available


    December 2018
  135. BERGMAN O, Karry R, Milhem J, Ben-Shachar D, et al
    NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.
    Mol Psychiatry. 2018 Dec 10. pii: 10.1038/s41380-018-0309.
    PubMed     Abstract available


  136. REAY WR, Atkins JR, Quide Y, Carr VJ, et al
    Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype.
    Mol Psychiatry. 2018 Dec 7. pii: 10.1038/s41380-018-0305.
    PubMed     Abstract available


    November 2018
  137. RADULESCU E, Jaffe AE, Straub RE, Chen Q, et al
    Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain.
    Mol Psychiatry. 2018 Nov 26. pii: 10.1038/s41380-018-0304.
    PubMed     Abstract available


  138. COLLIN G, Seidman LJ, Keshavan MS, Stone WS, et al
    Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program.
    Mol Psychiatry. 2018 Nov 8. pii: 10.1038/s41380-018-0288.
    PubMed     Abstract available


    October 2018
  139. PILLINGER T, D'Ambrosio E, McCutcheon R, Howes OD, et al
    Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 Oct 18. pii: 10.1038/s41380-018-0275.
    PubMed     Abstract available


  140. DOUCET GE, Moser DA, Luber MJ, Leibu E, et al
    Baseline brain structural and functional predictors of clinical outcome in the early course of schizophrenia.
    Mol Psychiatry. 2018 Oct 3. pii: 10.1038/s41380-018-0269.
    PubMed     Abstract available


    September 2018
  141. GUO JY, Ragland JD, Carter CS
    Memory and cognition in schizophrenia.
    Mol Psychiatry. 2018 Sep 21. pii: 10.1038/s41380-018-0231.
    PubMed     Abstract available


  142. WANG HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, et al
    mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0234.
    PubMed     Abstract available


  143. CAI HQ, Catts VS, Webster MJ, Galletly C, et al
    Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation.
    Mol Psychiatry. 2018 Sep 13. pii: 10.1038/s41380-018-0235.
    PubMed     Abstract available


    August 2018
  144. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2018 Aug 16. pii: 10.1038/s41380-018-0220.
    PubMed     Abstract available


    July 2018
  145. SEGEV A, Yanagi M, Scott D, Southcott SA, et al
    Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors.
    Mol Psychiatry. 2018 Jul 23. pii: 10.1038/s41380-018-0124.
    PubMed     Abstract available


    June 2018
  146. KUMAR J, Liddle EB, Fernandes CC, Palaniyappan L, et al
    Glutathione and glutamate in schizophrenia: a 7T MRS study.
    Mol Psychiatry. 2018 Jun 22. pii: 10.1038/s41380-018-0104.
    PubMed     Abstract available


  147. CAO B, Cho RY, Chen D, Xiu M, et al
    Treatment response prediction and individualized identification of first-episode drug-naive schizophrenia using brain functional connectivity.
    Mol Psychiatry. 2018 Jun 19. pii: 10.1038/s41380-018-0106.
    PubMed     Abstract available


  148. SUN D, Ching CRK, Lin A, Forsyth JK, et al
    Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Mol Psychiatry. 2018 Jun 13. pii: 10.1038/s41380-018-0078.
    PubMed     Abstract available


  149. CHAUMETTE B, Ferrafiat V, Ambalavanan A, Goldenberg A, et al
    Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.
    Mol Psychiatry. 2018 Jun 12. pii: 10.1038/s41380-018-0103.
    PubMed     Abstract available


  150. EGERTON A, Broberg BV, Van Haren N, Merritt K, et al
    Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE).
    Mol Psychiatry. 2018 Jun 7. pii: 10.1038/s41380-018-0082.
    PubMed     Abstract available


    May 2018
  151. PILLINGER T, D'Ambrosio E, McCutcheon R, D Howes O, et al
    Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 May 9. pii: 10.1038/s41380-018-0058.
    PubMed     Abstract available


  152. HAUBERG ME, Fullard JF, Zhu L, Cohain AT, et al
    Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
    Mol Psychiatry. 2018 May 8. pii: 10.1038/s41380-018-0059.
    PubMed     Abstract available


  153. YALLA K, Elliott C, Day JP, Findlay J, et al
    FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system.
    Mol Psychiatry. 2018;23:1278-1286.
    PubMed     Abstract available


  154. DEVANNA P, Chen XS, Ho J, Gajewski D, et al
    Next-gen sequencing identifies non-coding variation disrupting miRNA-binding sites in neurological disorders.
    Mol Psychiatry. 2018;23:1375-1384.
    PubMed     Abstract available


  155. ORHAN F, Fatouros-Bergman H, Goiny M, Malmqvist A, et al
    CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
    Mol Psychiatry. 2018;23:1244-1250.
    PubMed     Abstract available


  156. VAUCHER J, Keating BJ, Lasserre AM, Gan W, et al
    Cannabis use and risk of schizophrenia: a Mendelian randomization study.
    Mol Psychiatry. 2018;23:1287-1292.
    PubMed     Abstract available


    April 2018
  157. JAUHAR S, Veronese M, Nour MM, Rogdaki M, et al
    Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study.
    Mol Psychiatry. 2018 Apr 20. pii: 10.1038/s41380-018-0042.
    PubMed     Abstract available


  158. BOKU S, Izumi T, Abe S, Takahashi T, et al
    Copy number elevation of 22q11.2 genes arrests the developmental maturation of working memory capacity and adult hippocampal neurogenesis.
    Mol Psychiatry. 2018;23:985-992.
    PubMed     Abstract available


    March 2018
  159. CHOUINARD VA, Henderson DC, Dalla Man C, Valeri L, et al
    Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis.
    Mol Psychiatry. 2018 Mar 9. pii: 10.1038/s41380-018-0045.
    PubMed     Abstract available


  160. OSIMO EF, Beck K, Reis Marques T, Howes OD, et al
    Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Mol Psychiatry. 2018 Mar 6. pii: 10.1038/s41380-018-0041.
    PubMed     Abstract available


  161. SULLIVAN CR, Koene RH, Hasselfeld K, O'Donovan SM, et al
    Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia.
    Mol Psychiatry. 2018 Mar 1. pii: 10.1038/s41380-018-0035.
    PubMed     Abstract available


    February 2018
  162. KIM DD, Barr AM, Honer WG, Procyshyn RM, et al
    Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.
    Mol Psychiatry. 2018 Feb 8. pii: 10.1038/s41380-018-0022.
    PubMed    


  163. ZILHAO NR, Abdellaoui A, Smit DJA, Cath DC, et al
    Polygenic prediction of obsessive compulsive symptoms.
    Mol Psychiatry. 2018;23:168-169.
    PubMed    


  164. PAGE SC, Hamersky GR, Gallo RA, Rannals MD, et al
    The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner.
    Mol Psychiatry. 2018;23:304-315.
    PubMed     Abstract available


  165. ROFFMAN JL, Petruzzi LJ, Tanner AS, Brown HE, et al
    Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial.
    Mol Psychiatry. 2018;23:316-322.
    PubMed     Abstract available


  166. NOTTER T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, et al
    Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Mol Psychiatry. 2018;23:323-334.
    PubMed     Abstract available


  167. ST POURCAIN B, Robinson EB, Anttila V, Sullivan BB, et al
    ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties.
    Mol Psychiatry. 2018;23:263-270.
    PubMed     Abstract available


  168. EHRENREICH H, Mitjans M, Van der Auwera S, Centeno TP, et al
    OTTO: a new strategy to extract mental disease-relevant combinations of GWAS hits from individuals.
    Mol Psychiatry. 2018;23:476-486.
    PubMed     Abstract available


  169. SCARR E, Udawela M, Thomas EA, Dean B, et al
    Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Mol Psychiatry. 2018;23:295-303.
    PubMed     Abstract available


  170. XU J, Hartley BJ, Kurup P, Phillips A, et al
    Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.
    Mol Psychiatry. 2018;23:271-281.
    PubMed     Abstract available


    January 2018
  171. LIEBERMAN JA, Girgis RR, Brucato G, Moore H, et al
    Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.
    Mol Psychiatry. 2018 Jan 9. pii: mp2017249. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  172. DE VRIJ FM, Bouwkamp CG, Gunhanlar N, Shpak G, et al
    Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
    Mol Psychiatry. 2018 Jan 4. pii: 10.1038/s41380-017-0004.
    PubMed     Abstract available


  173. MITCHELL AC, Javidfar B, Pothula V, Ibi D, et al
    MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
    Mol Psychiatry. 2018;23:123-132.
    PubMed     Abstract available


    November 2017
  174. STEULLET P, Cabungcal JH, Bukhari SA, Ardelt MI, et al
    The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
    Mol Psychiatry. 2017 Nov 28. pii: mp2017230. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  175. CHENG CM, Chang WH, Chen MH, Tsai CF, et al
    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  176. ENWRIGHT III JF, Huo Z, Arion D, Corradi JP, et al
    Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia.
    Mol Psychiatry. 2017 Nov 7. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  177. KENDLER KS
    The genealogy of major depression: symptoms and signs of melancholia from 1880 to 1900.
    Mol Psychiatry. 2017;22:1539-1553.
    PubMed     Abstract available


    October 2017
  178. KELLY S, Jahanshad N, Zalesky A, Kochunov P, et al
    Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
    Mol Psychiatry. 2017 Oct 17. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  179. GREENE C, Kealy J, Humphries MM, Gong Y, et al
    Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.
    Mol Psychiatry. 2017 Oct 10. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  180. LEGGE SE, Hamshere ML, Ripke S, Pardinas AF, et al
    Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Mol Psychiatry. 2017;22:1502-1508.
    PubMed     Abstract available


    September 2017
  181. ZHOU Y, Dong F, Lanz TA, Reinhart V, et al
    Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment.
    Mol Psychiatry. 2017 Sep 19. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  182. SOLIMAN MA, Aboharb F, Zeltner N, Studer L, et al
    Pluripotent stem cells in neuropsychiatric disorders.
    Mol Psychiatry. 2017;22:1241-1249.
    PubMed     Abstract available


    August 2017
  183. ALACHKAR A, Wang L, Yoshimura R, Hamzeh AR, et al
    Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits.
    Mol Psychiatry. 2017 Aug 15. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  184. GUR RE, Bassett AS, McDonald-McGinn DM, Bearden CE, et al
    A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  185. NIMGAONKAR VL, Prasad KM, Chowdari KV, Severance EG, et al
    The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.
    Mol Psychiatry. 2017 Aug 1. doi: 10.1038/mp.2017.
    PubMed     Abstract available


    July 2017
  186. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 Jul 25. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  187. BENAMER N, Marti F, Lujan R, Hepp R, et al
    GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.
    Mol Psychiatry. 2017 Jul 11. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  188. RAO AR, Yourshaw M, Christensen B, Nelson SF, et al
    Rare deleterious mutations are associated with disease in bipolar disorder families.
    Mol Psychiatry. 2017;22:1009-1014.
    PubMed     Abstract available


    June 2017
  189. TENG S, Thomson PA, McCarthy S, Kramer M, et al
    Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia.
    Mol Psychiatry. 2017 Jun 20. doi: 10.1038/mp.2017.
    PubMed     Abstract available


    May 2017
  190. KIM Y, Giusti-Rodriguez P, Crowley JJ, Bryois J, et al
    Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.
    Mol Psychiatry. 2017 May 30. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  191. WEINSTEIN JJ, van de Giessen E, Rosengard RJ, Xu X, et al
    PET imaging of dopamine-D2 receptor internalization in schizophrenia.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  192. MOBERGET T, Doan NT, Alnaes D, Kaufmann T, et al
    Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls.
    Mol Psychiatry. 2017 May 16. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  193. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  194. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  195. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2017 May 2. doi: 10.1038/mp.2017.
    PubMed     Abstract available


    April 2017
  196. DUNCAN LE, Ratanatharathorn A, Aiello AE, Almli LM, et al
    Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
    Mol Psychiatry. 2017 Apr 25. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  197. HADAR R, Bikovski L, Soto-Montenegro ML, Schimke J, et al
    Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia.
    Mol Psychiatry. 2017 Apr 4. doi: 10.1038/mp.2017.
    PubMed     Abstract available


    March 2017
  198. NOTTER T, Meyer U
    Microglia and schizophrenia: where next?
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed    


  199. PARKER KL, Kim YC, Kelley RM, Nessler AJ, et al
    Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  200. LYALL AE, Pasternak O, Robinson DG, Newell D, et al
    Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  201. DEVOR A, Andreassen OA, Wang Y, Maki-Marttunen T, et al
    Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Mol Psychiatry. 2017 Mar 28. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  202. STEULLET P, Cabungcal JH, Coyle J, Didriksen M, et al
    Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.
    Mol Psychiatry. 2017 Mar 21. doi: 10.1038/mp.2017.
    PubMed     Abstract available


  203. WESSELING H, Xu B, Want EJ, Holmes E, et al
    System-based proteomic and metabonomic analysis of the Df(16)A+/- mouse identifies potential miR-185 targets and molecular pathway alterations.
    Mol Psychiatry. 2017;22:384-395.
    PubMed     Abstract available


    January 2017
  204. WEBER-STADLBAUER U, Richetto J, Labouesse MA, Bohacek J, et al
    Transgenerational transmission and modification of pathological traits induced by prenatal immune activation.
    Mol Psychiatry. 2017;22:102-112.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: